Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Sarah Elkourashy, Consultant in Clinical Hematology and BMT at Hamad Medical Corporation, Assistant professor of clinical medicine at Weill Cornell Medicine-Qatar, shared on LinkedIn:
”Happy to be part of ASH Conference 2025 – ASH2025
It was a pleasure reconnecting with former colleagues and engaging with peers from across the hematology community.
The meeting offered valuable insights into the latest advances in hematology and meaningful discussions on how to further enhance the care of patients with hematological disorders.
Thankful for the rich scientific exchange and collaborative environment.
Delighted to present our poster there Shehab Mohamed, Abdulrahman Al-Mashdali

Abstracts accepted:
1.Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective study cohort
Read the full article in Blood.
Authors: Rawan Dawoud, Farah Jibril, Maria Benkhadra, Sahar Nasser, Amaal Gulied, Anas Hamad, Honar Charif, Mohamed Yassin, Ruba Yasin Taha, Safaa Alazawi, Hesham Elsabah, Deena Mudawi, Sarah Elkourashy, Shereen Elazzazy
2.Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity
Read the full article in Blood.
Authors: Maria Benkhadra, Abdulrahman Al-Mashdali, Sarah Elkourashy, Anas Hamad, Shehab Mohamed, Halima El Omri, Honar Cherif

3.Caplacizumab for pediatric immune thrombotic thrombocytopenic purpura: A scoping review of current evidence
Read the full article in Blood.
Authors: Abdulrahman Al-Mashdali, Samah M Salihb, Priyadarshini Vatsyayanc, Deena Mudawi, Sarah Elkourashy, Dina Soliman, Honar Charif, Shehab Mohamed

All from ASH25 featured in Hemostasis Today.
-
Aug 22, 2026, 17:05Mostafa Elshazly: Managing Anticoagulant-Related Bleeding in Clinical Practice
-
Aug 22, 2026, 17:01Cesarovic Nikola: FDA Data Reanalysis Raises Questions About Moderna’s mFLUSIVA Risk-Benefit Profile
-
Aug 22, 2026, 16:38Andreas Linkermann: Decoding the Chain Reaction of Ferroptotic Cell Death
-
Aug 22, 2026, 16:33Nicolas Hulscher: FDA Data Reanalysis Raises Alarms Over Moderna’s MFLUSIVA
-
Aug 22, 2026, 16:19Moti Haim: Transforming AF Care in the Elderly
-
Aug 22, 2026, 16:12Hussam Hammoud: A Slap Is Not “Just a Slap” When the Patient Has Hemophilia
-
Aug 22, 2026, 15:53Howard Smith: Publix’s GreenWise Organic Frozen Berries Have E. coli Contamination
-
Aug 22, 2026, 15:13Arthur Allen: Empowering Clinicians to Act
-
Aug 22, 2026, 15:11Bassem M. Mohammed: Factor VIII Structure Analysis Makes the Cover of the Journal of Thrombosis and Haemostasis